Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaMarco L. Davila, Renier J. Brentjens, Qing He et al.|Science Translational Medicine|2014Cited by 2.5k
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K. Stein‐Thoeringer, Eran Elinav, Neeraj Saini et al.|Nature Medicine|2023Cited by 226
4-1BB enhancement of CAR T function requires NF-κB and TRAFsGongbo Li, Marco L. Davila|JCI Insight|2018Cited by 147
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Saini, Koichi Takahashi, David M. Swoboda et al.|Blood Cancer Discovery|2022Cited by 72
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host diseaseBishwas Shrestha, Marco L. Davila|Journal of Clinical Investigation|2020Cited by 60